ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚̐­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > •½¬25”N“x@Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > Ž–‘O•]‰¿ˆÏˆõ‰ï–¼•ë > ƒGƒCƒY‘΍ôŒ¤‹†Ž–‹Æ

ƒGƒCƒY‘΍ôŒ¤‹†Ž–‹Æ

i›FˆÏˆõ’·j

 
’rã@çŽõŽq “Á’è”ñ‰c—˜Šˆ“®–@l‚Õ‚ê‚¢‚·“Œ‹ž—Ž–
ƒZƒNƒ\ƒƒW[
uŽv‚¢‚±‚݂̐«AƒŠƒXƒL[‚ȃZƒbƒNƒXv’rãçŽõŽq’˜AŠâ”g‘“XA2011
u21¢‹I‚̉ۑ聁¡‚±‚»AƒGƒCƒY‚ðl‚¦‚év’rãçŽõŽq’˜@à’c–@l“ú–{«‹³ˆç‹¦‰ï@«‹³ˆçƒnƒ“ƒhƒuƒbƒNvol.5 2011
uƒGƒCƒYESTD‚Ɛ«‚Ì‹³ˆçv’rãçŽõŽq‘¼‹¤’˜@\ŒŽŽÉ@2002
 
¡‘º@’m–¾ “Þ—ÇŒ§—§ˆã‰È‘åŠwE‹³Žö
ŒöO‰q¶ŠwAŒ’N­ôˆãŠwAˆã—Эô
‚`‚h‚c‚r^Š´õŽÒV‹K•ñ”ä—¦|‚¢‚í‚ä‚éu‚¢‚«‚È‚è‚`‚h‚c‚r—¦v|‚ÌŒŸ“¢. ¬ìr•vA”’â‘ô–A¡‘º’m–¾. “ú–{ƒGƒCƒYŠw‰ïŽ. 2012 Feb;14(1):46-54.
‚g‚h‚uf—ÂɊւí‚錴‰¿‚ÌŽÀ‘Ô’²¸. ˆäo”Ž¶AÔ‰HŠwA”’ã‘ô–A¡‘º’m–¾. “ú–{ƒGƒCƒYŠw‰ïŽ. 2010 Feb;12(1):49-55.
History of public health crises in Japan. Imamura T, Ide H, Yasunaga H. J Public Health Policy. 2007 Nov;28(2):221-237
 
Šâ–{@ˆ¤‹g “Œ‹ž‘åŠwˆã‰ÈŠwŒ¤‹†ŠE‹³Žö
Š´õÇŠwEƒEƒCƒ‹ƒXŠw
Kikuchi, T., Iwatsuki-Horimoto, K., Adachi, A., Koga, M., Nakamura, H., Hosoya, N., Kawana-Tachikawa, A., Koibuchi, T., Miura, T., Fujii, T., Kawaoka, Y., and Iwamoto, A. Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults. Vaccine 30: 3819-3823, 2012. EPub April 10, 2012.
Kondo, N., Miyauchi, K. Meng, F. Iwamoto, A. and Matsuda, Z. Conformational changes of the HIV-1 envelope protein during membrane fusion were inhibited by the replacement of its membrane-spanning domain. J. Biol. Chem. 285:14681-14688, 2010. May 7, 2010.
Miyazaki, E., Kawana-Tachikawa, A., Tomizawa, M., Nunoya, J., Odawara, T., Fujii, T., Shi, Y., Gao, G.F., and Iwamoto, A. Highly restricted TCR repertoire in the CD8-positive T cell response against an HIV-1 epitope with a stereotypic amino acid substitution. AIDS 23:651-660, 2009.
 
¬–쎛@ºˆê •xŽmŽs—§’†‰›•a‰@E‰@’·A“Œ‹žŽœŒb‰ïˆã‰È‘åŠw‹qˆõ‹³Žö
”å”AŠí‰ÈA”A˜HE«ŠíŠ´õÇAŠ´õ§Œä
Comparison of free and anonymous testing for HIV and sexually@transmitted infections between the University Hospital and Health@Center. Yoshida M, Chiba A, Kawano S, Kato T, Sato F, Horino T, Nakazawa Y, Yoshikawa K, Onodera S, Hori S. J Infect Chemother. 2012 Mar 23.[Epub ahead of print]
HIVŠ´õŽÒ‚Ì”~“Å‚ÉŠÖ‚·‚錟“¢.²“¡•¶Æ,‰Í–ì^“ñ,‰Á“¡“N˜N,–x–ì“N–ç,’†àV –õ,‹gìWŽi,‹g“c³Ž÷,¬–쎛ºˆê.“ú«Š´õÇ‰ïŽ20i1jF2009F192-197.
¬–쎛ºˆêFŒú¶˜J“­‰ÈŠwŒ¤‹†•â•‹à VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU“™V‹»EÄ‹»Š´õÇŒ¤‹†Ž–‹Æu«Š´õÇ‚ÉŠÖ‚·‚é—\–hAŽ¡—Â̑̌n‰»‚ÉŠÖ‚·‚錤‹†viŒ¤‹†‘ã•\ŽÒF¬–쎛ºˆêj•½¬21”N“x`•½¬23”N“x‘‡Œ¤‹†•ñ‘
›
‘q“c@‹B ‘Ûˆã—ÕŸŽƒ‘åŠw‰–’J•a‰@
ƒEƒCƒ‹ƒXŠ´õÇ
Intranasal administration ofadjyvant-combined vaccine protects Monkeys from challenge with the highly pathogenic infkuenza A H5N1 Virus. Ichinihe T. Ainai A. Ami Y Nagata N.Iwata N.Kawaguchi A. Suzuki Y. Odagiri T.Tashiro M.Takahashi H. Strayer DR.Carter WA.Chia j.Tamura S. Sata T. Kurata T. Hasegawa H. J.Med.Virol.2010.82:1754-1761.
Continuity and change of Japanese encephalitis virus in Toyama pre-Fecture.Japan. Obara M. Yamauchi T. Watanabe M. Hasegawa S. UedaY. Matsuno K. Iwai M. Horimoto E. Kurata T. Takizawa T. Kariwa H. Takashima I. American J. Trop. Med. & Hygiene 2011. 84:695-708
Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated infkuennza vacnine.
Ainai A. Tamura S. Suzuki T. Ito R. Asanuma H.,Tanimoto T.Gomi Manabe S. Ishikawa T.Okuno Y. Odagiri T. Tashiro M.Sata T.Kurata T. And Hasegawa H. J. Med. Virol.2012. 84.336-344
 
‘ŠŠy@—TŽq Š‘®‚È‚µ
—Տ°Š´õÇŠw
“ˆ‹MŽqC{“¡O“ñC‹ß“¡^‹KŽqC‘qˆä‰ØŽqC‘ŠŠy—TŽqC¡ˆäŒõMFŒuŒõy‘f–Ɖu‘ª’è–@‚É‚æ‚éV‚µ‚¢HIVRŒ´R‘Ì“¯ŽžŒŸoŽŽ–òi‘æ4¢‘ãj‚ÌŒŸ“¢DŠ´õÇŠw‰ïŽ81F562-572C2007
’ËŒ´—DŒÈC‘ŠŠy—TŽqCŠì‘½P˜aC“ˆ‹MŽqC–î‰i—R—ŽqCŠOì³¶C‘å‹à”ü˜aCˆî—tŒ›”VF‘æ20‰ñ“ú–{ƒGƒCƒYŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€ Š´õ—«‚Ì”DPEoŽYEˆçŽ™Žx‰‡D“ú–{ƒGƒCƒYŠw‰ïŽ9F116-119C2007D
Mohri S, Yoshikawa K, Sagara H, Nakajima, HFA case of Penicillium marneffei infection in an AIDS patient -the first case in Japan-. Jpn J
Med Mycol 41: 23-26, 2000.
 
‹{“c@ˆê—Y ƒGƒCƒY—\–hà’c—Ž–
Š´õÇŠwEŒŒ‰t“à‰ÈŠw
w¢ŠE‚̓GƒCƒY‚Æ‚Ç‚¤“¬‚Á‚Ä‚«‚½‚Ì‚©x ‹{“cˆê—Y ƒ|ƒbƒgo”Å 2002”N
‘æ24‰ñ“ú–{ƒGƒCƒYŠw‰ïƒjƒ…[ƒYƒŒƒ^[1`7i•Ò’˜j@‹{“cˆê—YE‰iˆÕŽŠ•¶ 2010”N4ŒŽ`12ŒŽ
wVƒGƒCƒY—\–hŽwj‚ÆŽ„‚½‚¿xi•Ò’˜j ƒGƒCƒY—\–hà’c•Òi‹{“cˆê—YE‰iˆÕŽŠ•¶j ˜A‡o”Å 2012”N

ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚̐­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > •½¬25”N“x@Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > Ž–‘O•]‰¿ˆÏˆõ‰ï–¼•ë > ƒGƒCƒY‘΍ôŒ¤‹†Ž–‹Æ

ƒy[ƒW‚̐擪‚Ö–ß‚é